Chronic Hemodialysis (CHD) in diabetic patients with Chronic Renal Failure (CRF) in Chile. Prospective study. Inicial report

2000 ◽  
Vol 50 ◽  
pp. 255
Author(s):  
Fernando A Bello ◽  
María F Bello ◽  
Claudio Parra ◽  
Marcela Rocha ◽  
Gabriel Villagrán
1994 ◽  
Vol 14 (3) ◽  
pp. 236-239 ◽  
Author(s):  
Edward C. Kohaut ◽  
F. Bryson Waldo ◽  
Mark R. Benfield

Objectives To determine the effect of changing dialysate volume on urea and glucoseequilibration curves and to determine, if dialysate volume is prescribed on the basis of body surface area, whether equilibration curves will be consistent in patients of different sizes and ages. Design A prospective study wherein children with acute or chronic renal failure had peritoneal equilibration studies done with dwell volumes of 30 mL/kg, 40 mL/kg, and 1200 mL/m2. Patient Population Twenty-two children: 7 under 3 years of age; 8 between 3 and 10 years of age; 7 older than 10 years of age. Statistics Student's t-test. Results Urea and glucose equilibrated rapidly at dwell volumes of 30 mL/kg, slower at dwell volumes of 40 mL/kg, and slowest at dwell volumes of 1200 mL/m2. Equilibration curves were similar in children of different ages when dialysate volumes of 1200 mL/m2 were infused. Conclusion Dialysate volumes of 1200 mL/m2 should be used when equilibration studies are being done to compare individuals of different ages and sizes.


Diabetes Care ◽  
1992 ◽  
Vol 15 (8) ◽  
pp. 976-979 ◽  
Author(s):  
P. J. Guillausseau ◽  
J. Peynet ◽  
P. Chanson ◽  
A. Legrand ◽  
J. J. Altman ◽  
...  

2009 ◽  
Vol 66 (3) ◽  
pp. 378-385 ◽  
Author(s):  
C. Papageorgiou ◽  
P. Ziroyannis ◽  
J. Vathylakis ◽  
A. Grigoriadis ◽  
V. Hatzikonstantinou ◽  
...  

2009 ◽  
Vol 29 (7) ◽  
pp. 707-709 ◽  
Author(s):  
Taro Nonaka ◽  
Akira Kikuchi ◽  
Naoko Kido ◽  
Yasuhiro Takahashi ◽  
Kyoko Yamada ◽  
...  

1981 ◽  
Author(s):  
M Bern ◽  
J Green

Sulfinpyrazone can reduce the incidence of thrombosis of A-V shunts in chronic renal failure. The drug is also reported to prevent acute deaths from coronary artery disease. This study was to determine mechanisms for these protective effects.Patients on chronic hemodialysis served as the study models. Six patients on dialysis three times per week for 6 or more months received sulfinpyrazone 200 mgm t.i.d. p.o. for 14 days. Blood samples were obtained before dialysis was begun before and after the 14 days of drug therapy.Results are shown as mean ± standard error of mean.AT III levels rose significantly by functional and immune assays. Functional levels (by von Kaulla technique) rose 24.5 ± 3.1 sec. to 47.3 + 5.5 sec. (P>.005) Plasma protein AT III (by radial immunodiffusion) rose 31.2 ± 2.17 mg/dl to 37.9 ± 2.1 mgm/dl. (P>.01) Platelet factor 4 (by Abbot radioimmunology assay) fell from 46.4 + 13.6 ngm/ml to 9.5 ± 1.1 ngm/ml.(P>.005) The concentration of thrombin-anti-thrombin complex (by R. Rosenberg, Harvard Medical School, Boston) rose from 4.2 ± .09 to 8.4 ± 1.0 (P>.005)Thus it appears that sulfinpyrazone elevates antithrombin concentration and function while simultaneously suppressing platelet release. These two effects may or may not be mutually dependent. The clinical efficacy of sulfinpyrazone may relate in part to the elevation of antithrombin III, probably by inhibiting its consumption, while also inhibiting platelet function.


1970 ◽  
Vol 10 (3) ◽  
pp. 152-158
Author(s):  
MH Fathelrahman

Background: The term of anemia of chronic renal failure (CRF) in sufficiency refers to that anemia resulting directly from failure of the endocrine and excretory functions of the kidney and decreased production of erythropoietin by damaged kidneys. The serum erythropoietin level in patients with renal failure does not increase in response to the developing anemia, which is the primary cause of inadequate erythropoiesis. Aim: The purpose of our study was to examine, among patients with CRF, the combined association of CRF and anemia on adverse outcomes. Settings and Design: A hospitalized study using administrative data, we identified all patients hospitalized with CRF in IBN-Sena hospital and Khartoum teaching hospitals, Khartoum, Sudan. Materials and Methods: This was a retrospective cohort study of 500 patients having a diagnosis of chronic renal failure hospitalized and discharged between October 2007 to February 2010 from two Sudanese Teaching hospitals (Khartoum and IBN-Sena). All adult patients with chronic renal failure hospitalized for hemodialysis. Results: Hemoglobin level was recorded for 500 members (100%) of the cohort. The mean (SD) hemoglobin was 13.0 g/dL (2.2) range from 11.8 g/dL to 14.6 g/dL. On admission, an hemoglobin of ≥ 14 g/dL was found in 36.2% of the patients, 36.2% had an hemoglobin between 12 g/dL and 14 g/dL, 19.6% between 10 g/dL and 12 g/dL, and 8% ≤ 10 g/dL. The proportion of patients with CRF was associated with increasing anemia. Conclusion: The results obtained indicated the further evidence that the concomitant presence of either CRF or anemia increased the risk of dying in the hospital or of being readmitted within 30 days among patients hospitalized. The association persisted after controlling for other factors associated with adverse outcomes in these patients. Key words: Anemia, chronic renal failure. DOI: http://dx.doi.org/ 10.3329/bjms.v10i3.8357 BJMS 2011; 10(3): 152-158


Sign in / Sign up

Export Citation Format

Share Document